Shlomo Yanai Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

AMRX Quotes by TradingView

Shlomo Yanai is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 245,727 shares of AMRX, which is worth approximately $1.9 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 76,453 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 246K
0% 3M change
45.17% 12M change
Total Value Held $1.9 Million

Shlomo Yanai Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Exercise of conversion of derivative security
-
76,453 Added 23.73%
245,727 Class A Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
80,128 Added 32.13%
169,274 Class A Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
35,406 Added 28.43%
89,146 Class A Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
-
46,218 Added 46.24%
53,740 Class A Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
-
7,522 Added 50.0%
7,522 Class A Common Stock

Also insider at

PM
Philip Morris International Inc. Consumer Defensive
Director
SY

Shlomo Yanai

Director
New York, NY

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMRX